VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Shane Stokes
August 9, 2017
In today’s Daily News Digest: Küng wins stage two time trial at the BinckBank Tour; Report: top squads look set to miss world team time trial championships; Kwiatkowski signs on for three more years with Team Sky; Under pressure from USADA, Colorado Classic abandons partnership with Armstrong; Vuelta pays tribute to career of Contador; Report: Trek-Segafredo aiming to replace Contador with Aru; UAE Team Emirates extends with Marcato, Conti and five others; Lingering effects of concussion force Dunbar to end season early; OVO Energy Tour of Britain confirms teams for 2017 edition; CAS confirms UCI’s four year suspension of Oyarzun; Research shows huge health benefits of commuting by bike; Eskapee’s rules for mountain bike riding; Video: Tony Martin falls during BinckBank Tour TT; Video: Tony Martin speaks after his crash; Video: Viviani skilfully avoids time trial fall in BinckBank Tour; Video: Peter Sagan celebrates Monday’s sprint win
The UCI confirmed on Tuesday that a four-year ban previously handed down to Chilean rider Carlos Oyarzun has been upheld by the Court of Arbitration for Sport. Oyarzun tested positive for the blood-boosting agent FG-4592 at the 2015 Pan American Games, where he won the time trial.
He was provisionally suspended in July 2015, then given an official four-year ban last August. Oyarzun sought to fight this suspension in CAS, but has now learned that this bid was unsuccessful.
“The CAS confirmed that Mr. Oyarzun committed an Anti-Doping Rule Violation and upheld the four-year sanction imposed on him,” stated the UCI.
Oyarzun previously won two Pan American titles, taking the road race in 2010 and the time trial in 2013. He competed for the Movistar team in 2011, riding the Giro d’Italia, and won the Vuelta Ciclista del Uruguay in 2015 while with the Keith Mobel – Partizan team.